Strong drug sales stoke Bristol-Myers

Bristol-Myers Squibb reports markedly higher second-quarter earnings early helped by strong sales of its blood-thinning medication Plavix and antidepressant Abilify.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.